Eloxx Pharmaceuticals Inc. (ELOX) stock fell during current market trading. What’s new?
Eloxx Pharmaceuticals Inc. (NASDAQ: ELOX) stock declined by 14.77% in the current market trading. Eloxx Pharmaceuticals, Inc. is working on developing new ribosome modulating agents (RMAs) using its TURBO-ZM chemical technology platform and its portfolio of Eukaryotic Ribosome Selective Glycosides. ELX-02, Eloxx’s primary investigational drug candidate, is a small molecule therapeutic candidate that aims to […]